Investor Relations

As Reported Financials

As Reported Financials

Source Document Currency Code (in thousands) 2014 Y 12/31/2016 USD 2015 Y 12/31/2017 USD 2016 Y 12/31/2017 USD 2017 Y 12/31/2017 USD
Source Document Currency Code 2014 Y 12/31/2016 USD 2015 Y 12/31/2017 USD 2016 Y 12/31/2017 USD 2017 Y 12/31/2017 USD

Cash flows from operating activities

Net income attributable to the Company 68,815 64,925 71,628 40,591

Adjustments to arrive at net income from continuing operations

Net income attributable to noncontrolling interests 4,750 4,407 4,157 4,468
Net pre-tax gain from operating activities of discontinued operations (11,258) (11,234) (9,452) (8,326)
Tax expense from discontinued operations 5,098 4,823 3,911 3,456
Net income from continuing operations 67,405 62,921 70,244 40,189

Adjustments to reconcile net income from continuing operations to net cash provided by/ (used in) operating activities

Depreciation and amortization 19,378 22,187 23,441 21,023
Net income attributable to noncontrolling interests (4,750) (4,407) (4,157) (4,468)
Stock compensation, net of cancellations 6,239 9,820 4,112 8,275
Impairment of goodwill 0 0 9,528 24,901
Provision/ (credit) for loan losses (6,400) (1,555) (6,935) (7,669)
Loans originated for sale (71,858) (153,445) (80,539) (53,287)
Proceeds from sale of loans held for sale 71,440 153,679 85,814 52,508
(Gain)/loss on sale of affiliates or offices 0 0 (2,862) 1,264
Deferred income tax expense/ (benefit) 5,058 (4,575) 2,777 22,845
Net decrease/ (increase) in other operating activities 14,387 2,852 (817) (8,466)
Net cash provided by/ (used in) operating activities of continuing operations 100,899 87,477 100,606 97,115
Net cash provided by/ (used in) operating activities of discontinued operations 6,160 6,411 5,541 4,870
Net cash provided by/ (used in) operating activities 107,059 93,888 106,147 101,985

Cash flows from investing activities

Investment securities available-for-sale

Purchases (335,404) (506,529) (422,315) (177,021)
Sales 6,450 34,160 50,049 148,407
Maturities, redemptions, and principal payments 190,926 208,467 165,768 120,546

Investment securities held-to-maturity

Purchases (48,835) 0 0 (14,945)
Principal payments 19,263 23,741 22,522 32,912
(Investments)/ distributions in trusts, net (385) (165) (508) (952)
Purchase of additional Bank Owned Life Insurance (“BOLI”) NA 0 0 (50,000)
(Purchase)/ redemption of Federal Home Loan Bank and Federal Reserve Bank stock 6,331 (2,900) (8,896) (15,896)
Net increase in portfolio loans (221,256) (452,675) (403,670) (390,003)
Proceeds from recoveries of loans previously charged-off 11,163 6,253 10,461 5,197
Proceeds from sale of OREO 1,102 277 1,337 1,644
Proceeds from sale of portfolio loans 58,568 NA NA NA
Net payment for sale of offices and related deposits 0 0 (98,517) 0
Capital expenditures, net of sale proceeds (9,705) (5,419) (9,011) (14,204)
Cash received from dispositions, net of cash divested/ (cash paid for acquisitions, including cash paid for deferred acquisition obligations, net of cash acquired) (44,845) NA NA NA
Cash provided by/ (used in) other investing activities of continuing operations (1,601) NA NA NA
Net cash provided by/ (used in) investing activities of continuing operations (368,228) NA NA NA
Net cash provided by/ (used in) investing activities-discontinued operations 0 NA NA NA
Net cash provided by/ (used in) investing activities (368,228) (694,790) (692,780) (354,315)

Cash flows from financing activities

Net increase in deposits 343,509 586,558 148,303 425,100
Net (decrease)/ increase in securities sold under agreements to repurchase and other (71,857) 27,719 1,409 (27,455)
Net (decrease)/ increase in short-term Federal Home Loan Bank borrowings 10,000 40,000 310,000 40,000
Net increase/ (decrease) in federal funds purchased 0 0 80,000 (50,000)
Advances of long-term Federal Home Loan Bank borrowings 55,000 123,636 134,779 50,110
Repayments of long-term Federal Home Loan Bank borrowings (62,104) (72,462) (171,898) (130,634)
Repurchase of common stock 0 0 (9,323) 0
Dividends paid to common shareholders (25,829) (29,608) (33,110) (37,054)
Dividends paid to preferred shareholders (3,475) (3,475) (3,475) (3,475)
Tax benefit/ (deficiency) from certain stock compensation awards 1,294 (1,262) (620) 0
Proceeds from warrant exercises NA 0 0 3,003
Proceeds from stock option exercises 1,807 1,206 1,725 882
Proceeds from issuance of common stock, net (353) (515) 842 171
Distributions paid to noncontrolling interests (4,426) (4,611) (4,054) (4,360)
Other equity adjustments (1,669) (199) (82) 26
Net cash provided by/ (used in) financing activities of continuing operations 241,897 NA NA NA
Net cash provided by/ (used in) financing activities-discontinued operations 0 NA NA NA
Net cash provided by/ (used in) financing activities 241,897 666,987 454,496 266,314
Net increase/ (decrease) in cash and cash equivalents (19,272) 66,085 (132,137) 13,984
Cash and cash equivalents at beginning of year 191,881 172,609 238,694 106,557
Cash and cash equivalents at end of year 172,609 238,694 106,557 120,541

Supplementary schedule of non-cash investing and financing activities

Cash paid for interest 30,043 27,749 27,415 33,502
Cash paid for income taxes, net of (refunds received) 30,072 33,318 33,078 32,159
Change in unrealized gain/ (loss) on securities available-for-sale, net of tax 3,740 (1,488) (11,689) 4,497
Change in unrealized gain/ (loss) on cash flow hedges, net of tax (160) 800 518 878
Change in unrealized gain/ (loss) on other, net of tax (80) (115) 123 50

Non-cash transactions

Transfer of net assets into held for sale NA 0 0 58,034
Loans transferred into other real estate owned from loan portfolio 56,967 NA NA NA
Loans charged-off (5,296) (2,036) (3,949) (863)
Loans transferred into/ (out of) other real estate owned from/ (to) held for sale or portfolio 298 0 1,944 0
Reversal of contingent consideration into income 0 2,026 0 0
Equity issued for acquisitions, including deferred acquisition obligations 21,007 NA NA NA
Data shown on this page is extracted directly from the company’s documents. S&P makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company’s presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, S&P, as always, stands by its commitment to the quality of the data.

Caution: External Link

You are leaving the Boston Private website. By clicking "Continue" below, you will enter a website created, operated, and maintained by a private business or organization. Boston Private provides this link as a service to our website visitors. We are not responsible for the content, views, or privacy policies of this site. We take no responsibility for any products or services offered by this site, nor do we endorse or sponsor the information it contains. 

Continue Cancel - Stay on BostonPrivate.com